EU, US & Japan Tackle Difficulties With Randomized Trials Involving Multi-Drug Resistant Bacteria

 
• By Neena Brizmohun
Streamlined
Aligned EU, US and Japanese trial data requirements should stimulate antibiotic development • Source: Shutterstock

More from Clinical Trials

More from R&D